Lower Incidence of Cytomegalovirus and BK Virus Adverse Events with Everolimus Versus Mycophenolate Was Maintained over 24 Months in De Novo Renal Transplant Recipients.
AMERICAN JOURNAL OF TRANSPLANTATION（2011）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要